Horng‐Yih Ou

Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

W. Timothy Garvey, Juan P. Frías, Ania M. Jastreboff et al. · The Lancet · 2023 · 590 citations · Full text

Obesity, Metabolic Syndrome, Diabetes Management +6

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 586 citations

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Enigmatic Ectopic Fat: Prevalence of Nonalcoholic Fatty Pancreas Disease and Its Associated Factors in a Chinese Population

Chih‐Yuan Wang, Horng‐Yih Ou, Ming‐Fong Chen et al. · Journal of the American Heart Association · 2014 · 203 citations · Full text

The Association between Nonalcoholic Fatty Pancreas Disease and Diabetes

Horng‐Yih Ou, Chih‐Yuan Wang, Yi‐Ching Yang et al. · PLoS ONE · 2013 · 160 citations · Full text

The association between self‐reported sleep quality and overweight in a Chinese population

Hao‐Chang Hung, Yi‐Ching Yang, Horng‐Yih Ou et al. · Obesity · 2013 · 95 citations · Full text